An Alzheimer’s pill appears to protect some in a high-risk population
(By Jon Hamilton for NPR published October 29, 2025) In April, the future was looking bleak for an experimental Alzheimer’s
Read More(By Jon Hamilton for NPR published October 29, 2025) In April, the future was looking bleak for an experimental Alzheimer’s
Read More(Source – news.va.gov) Veterans facing the challenges of early stage Alzheimer’s disease now have a powerful ally in the San
Read More(By Jon Hamilton for NPR) Joe Walsh, 79, is waiting to inhale. He’s perched on a tan recliner at the
Read More(By Jon Hamilton for NPR) A new generation of blood tests promises to change the way doctors diagnose and treat
Read More(By Jon Hamilton for NPR) Advisors to the Food and Drug Administration have recommended unanimously that the agency approve the
Read More(By Judith Graham for KFF Health News) The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and
Read More(By Rylee Wilson for Becker’s Hospital Review) CMS is proposing broader coverage of PET scans for patients with Alzheimer’s disease,
Read More(By Arthur Allen for KFF Health News) This week the FDA is expected to approve what many scientists and doctors
Read More(By Kerry Dooley Young for STAT) Medicare’s decision to withhold coverage for Biogen’s Aduhelm despite the Food and Drug Administration’s
Read More(By Rylee Wilson for Becker’s Hospital Review) Twenty-six state attorneys general are asking Medicare to cover monoclonal antibody treatments for
Read More